Lexicon Pharmaceuticals I... (LXRX)
NASDAQ: LXRX
· Real-Time Price · USD
0.92
0.02 (2.39%)
At close: Jun 26, 2025, 3:59 PM
0.93
0.79%
After-hours: Jun 26, 2025, 06:40 PM EDT
2.39% (1D)
| Bid | 0.9 |
| Market Cap | 335.47M |
| Revenue (ttm) | 31.21M |
| Net Income (ttm) | -177.3M |
| EPS (ttm) | -0.5 |
| PE Ratio (ttm) | -1.85 |
| Forward PE | -2.51 |
| Analyst | Hold |
| Ask | 0.94 |
| Volume | 4,903,826 |
| Avg. Volume (20D) | 13,683,387 |
| Open | 0.90 |
| Previous Close | 0.90 |
| Day's Range | 0.77 - 0.97 |
| 52-Week Range | 0.28 - 2.45 |
| Beta | 1.01 |
About LXRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LXRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LXRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Lexicon Pharmaceuticals Inc. is scheduled to release its earnings on Jul 31, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-15.57%
Lexicon Pharmaceuticals shares are trading lower a...
Unlock content with
Pro Subscription
3 months ago
+64.13%
Lexicon Pharmaceuticals shares are trading higher after the company announced an exclusive license agreement with Novo Nordisk for LX9851.
1 month ago · seekingalpha.com
Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2025 Earnings Call TranscriptLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX ) Q1 2025 Earnings Conference Call May 13, 2025 5:00 PM ET Company Participants Lisa DeFrancesco - Senior Vice President, Investor Relations and Corporate St...
